Skip to main content
SpringerLink
Log in

Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity

  • Hematology/Oncology
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Recombinant human erythropoietin (rHuEPO) was administered subcutaneously three times a week to 18i infants with the anaemia of prematurity at doses of 75, 150, 300, or 600 units/kg per week for 4 weeks, starting at 3–4 weeks of postnatal age. A significant and dose-dependent increase in reticulocyte count was observed from a mean baseline value of 71×109/l to 200×109/l after 3 weeks of therapy, compared with a change from 69 to 97×109/l in 66 historical controls. The haematocrit value remained unchanged during rHuEPO treatment, whereas it steadily declined until 9 weeks of postnatal age in the controls. These effects were accompanined by a marked reduction in serum iron concentration and transferrin saturation in patients receiving standard-dose iron supplements, but not in those given larger doses. Only 3 of 18 patients required a red blood cell transfusion. These infants were among the most anaemic at entry into the study and 2 of them were unable to complete rHuEPO therapy, while the third developed iron deficiency anaemia. These data indicate that rHuEPO with appropriate iron supplementation may accelerate the recovery from anaemia of prematurity. Larger scale placebo-controiled studies are now needed to confirm these findings and verify their impact on transfusion requirements of premature infants.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ANC:

absolute neutrophil count

ANOVA:

analysis of variance

AP:

anaemia of prematurity

EPO:

erythropoietin

rHuEPO:

recombinant human erythropoietin

References

  1. Beck D, Masserey E, Meyer M, Calame A (1991) Weekly intravenous administration of recombinant human erythropoietin in infants with the anaemia of prematurity. Eur J Pediatr 150:767–772

    PubMed  Google Scholar 

  2. Berridge MV, Fraser JK, Carter JM, Lin F-K (1988) Effects of recombinant human erythropoietin on megakaryocytes and on platelet production in the rat. Blood 72:970–977

    PubMed  Google Scholar 

  3. Bianchetti MG, Hämmerli I, Roduit C, Neuhaus TJ, Leumann EP, Oetliker OH (1991) Epoetin alfa in anaemic children or adolescents on regular dialysis. Eur J Pediatr 150:509–512

    PubMed  Google Scholar 

  4. Brown MS, Garcia JF, Phibbs RH, Dallman PR (1984) Decreased response of plasma immunoreactive erythropoietin to “available oxygen” in anemia of prematurity. J Pediatr 105:793–798

    PubMed  Google Scholar 

  5. Christensen R, Rothstein G (1979) Pitfalls in the interpretation of leukocyte counts of newborn infants. Am J Clin Pathol 12:608–611

    Google Scholar 

  6. Christensen RD, Koenig JM, Viskochil DH, Rothstein G (1989) Down-modulation of neutrophil production by erythropoietin in human hematopoietic clones. Blood 74:651–659

    Google Scholar 

  7. Eckardt K-U, Hartmann W, Vetter U, Pohlandt F, Burghardt R, Kurtz A (1990) Serum immunoreactive erythropoietin of children in health and disease. Eur J Pediatr 149:459–464

    PubMed  Google Scholar 

  8. Egrie J, Cotes P, Lane J, Gaines Das R, Tam R (1987) Development of radioimmunoassays for human erythropoietin using recombinant erythropoietin as tracer and immunogen. J Immunol Methods 99:235–241

    PubMed  Google Scholar 

  9. Erslev A (1991) Erythropoietin. N Engl J Med 324:1339–1344

    PubMed  Google Scholar 

  10. Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW (1989) Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 321:158–163

    PubMed  Google Scholar 

  11. Fraser JK, Tam AS, Lin F-K, Berridge MV (1989) Expression of specific high-affinity binding sites for erythropoietin on rat and mouse megakaryocytes. Exp Hematol 17:10–16

    PubMed  Google Scholar 

  12. Hågå P (1980) Plasma ferritin concentrations in preterm infants in cord blood and during the early anemia of prematurity. Acta Paediatr Scand 69:637–641

    PubMed  Google Scholar 

  13. Halpérin DS, Wacker P, Lacourt G, Félix M, Babel J-F, Aapro M, Wyss M (1990) Effects of recombinant human erythropoietin in infants with the anemia of prematurity. J Pediatr 116:779–786

    PubMed  Google Scholar 

  14. Iscove N, Sieber F, Winterhalter K (1974) Erythroid colony formation in cultures of mouse and human bone marrow; analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin-A. J Cell Physiol 83:309–320

    PubMed  Google Scholar 

  15. Koenig JM, Christensen RD (1990) Effect of erythropoietin on granulocytopoiesis: in vitro and in vivo studies in weanling rats. Pediatr Res 27:583–587

    PubMed  Google Scholar 

  16. Lundström U, Siimes MA, Dallman PR (1977) At what age does iron supplementation become necessary in low-birth-weight infants? J Pediatr 91:878–883

    PubMed  Google Scholar 

  17. Manroe B, Weinberg A, Rosenfeld C, Browne R (1979) The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 95:89–98

    PubMed  Google Scholar 

  18. Melhorn D, Gross S (1971) Vitamin E-dependent anemia in the premature infant. I. Effects of large doses of medicinal iron. J Pediatr 79:569–580

    PubMed  Google Scholar 

  19. Obladen M, Maier R, Segerer H, Grauel EL, Holland BM, Stewart G, Jorch G, Rabe H, Linderkamp O, Hoffmann HG, Houghton F, Herrmann Z, Scigalla P, Wardrop C (1991) Efficacy and safety of recombinant humanerythropoietin to prevent the anaemias of prematurity. In: Gurland H, Moran J, Samtleben W, Scigalla P, Wieczorek L (eds) Erythropoietin in renal and non-renal anemias. Karger, Basel, pp 314–326

    Google Scholar 

  20. Ohls RK, Christensen RD (1991) Administration of erythropoietin is a successful alternative to erythrocyte transfusions for infants with the anemia of prematurity. Pediatr Res 29:276a

    Google Scholar 

  21. Reed CDL, Fidler J, Oliver DO, Cotes PM, Pippard MJ, Winearls CG (1988) Erythroid progenitor cell kinetics in chronic haemodialysis patients responding to treatment with recombinant human erythropoietin. Br J Haematol 70:335–380

    PubMed  Google Scholar 

  22. Rhondeau SM, Christensen RD, Ross MP, Rothstein G, Simmons MA (1988) Responsiveness to recombinant human erythropoietin of marrow erythroid progenitors from infants with the “anemia of prematurity”. J Pediatr 112:935–940

    PubMed  Google Scholar 

  23. Schloesser L, Kipp M, Wenzel F (1965) Thrombocytosis in iron-deficiency anemia. J Lab Clin Med 66:107–114

    Google Scholar 

  24. Shannon KM (1990) Anemia of prematurity: progress and prospects. Am J Pediatr Hematol Oncol 12:14–20

    PubMed  Google Scholar 

  25. Shannon KM, Naylor GS, Torkildson JC, Clemons GK, Schaffner V, Goldman SL, Lewis K, Bryant P, Phibbs R (1987) Circulating erythroid progenitors in the anemia of prematurity. N Engl J Med 317:728–733

    PubMed  Google Scholar 

  26. Shannon KM, Mentzer WC, Abels RI, Freeman P, Newton N, Thompson D, Sniderman S, Ballard S, Phibbs RH (1991) Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study. J Pediatr 118:949–955

    PubMed  Google Scholar 

  27. Stockman III JA, Graeber JE, Clark DA, McClellan K, Garcia JF, Kavey REW (1984) Anemia of prematurity: determinants of the erythropoietin response. J Pediatr 105:786–792

    PubMed  Google Scholar 

  28. Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM (1986) Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet II:1175–1178

    Google Scholar 

  29. Xanthou M (1970) Leucocyte blood picture in healthy fullterm and premature babies during neonatal period. Arch Dis Child 45:242–249

    PubMed  Google Scholar 

  30. Zanjani E, Ascensao J, McGlave P, Panisadre M, Ash R (1981) Studies on the liver to kidney switch of erythropoietin production. J Clin Invest 67:1183–1188

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Paediatrics, Hôpital des Enfants, 30 Bd de la Cluse, CH-1211, Geneva 4, Switzerland

    D. S. Halpérin, M. Félix, P. Wacker, G. Lacourt, J. -F. Babel & M. Wyss

Authors
  1. D. S. Halpérin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Félix
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Wacker
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Lacourt
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. -F. Babel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Wyss
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Halpérin, D.S., Félix, M., Wacker, P. et al. Recombinant human erythropoietin in the treatment of infants with anaemia of prematurity. Eur J Pediatr 151, 661–667 (1992). https://doi.org/10.1007/BF01957568

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01957568

Key words

Search

Navigation